Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma [PDF]
Summary: Histone methyltransferase KMT2D harbors frequent loss-of-function somatic point mutations in several tumor types, including melanoma. Here, we identify KMT2D as a potent tumor suppressor in melanoma through an in vivo epigenome-focused pooled ...
Yu-Hsi Lin +2 more
exaly +5 more sources
Background Lysine methyltransferase 2D (KMT2D) mediates mono‐methylation of histone H3 lysine 4 (H3K4me1) in mammals. H3K4me1 mark is involved in establishing an active chromatin structure to promote gene transcription.
Changyan Ma, Bing Yao, Mengying Xing
exaly +3 more sources
Case Report: Exploring KMT2D mutation in Shone syndrome [PDF]
IntroductionShone syndrome is a rare congenital heart disease characterized by multilevel left-sided obstructive lesions. KMT2D variants cause Kabuki syndrome and are frequently associated with left-sided obstructive congenital heart defects, but their ...
Peiwen Cheng +4 more
doaj +4 more sources
Summary: The histone H3 lysine 4 (H3K4) methyltransferase KMT2D (also called MLL4) is one of the most frequently mutated epigenetic modifiers in many cancers, including medulloblastoma (MB).
Shilpa S Dhar, Min Gyu Lee, Calena Brown
exaly +4 more sources
Loss of Function of the Gene Encoding the Histone Methyltransferase KMT2D Leads to Deregulation of Mitochondrial Respiration [PDF]
KMT2D encodes a methyltransferase responsible for histone 3 lysine 4 (H3K4) mono-/di-methylation, an epigenetic mark correlated with active transcription.
Giuseppe Merla +2 more
exaly +4 more sources
Dysregulated KMT2D mutant targeting immunogenic rewiring to overcome epigenetic entropy promotes follicular lymphomagenesis [PDF]
Background Epigenetic modifier factors in B cell lymphomas often harbor loss-of-function mutations. Mutations occurring in the histone-lysine methyltransferase 2D (KMT2D) gene are the pivotal chromatin-modifying hallmarks of follicular lymphoma (FL ...
Yuqian Zhu +13 more
doaj +2 more sources
KMT2D Deficiency Promotes Myeloid Leukemias Which Is Vulnerable to Ribosome Biogenesis Inhibition
KMT2C and KMT2D are the most frequently mutated epigenetic genes in human cancers. While KMT2C is identified as a tumor suppressor in acute myeloid leukemia (AML), the role of KMT2D remains unclear in this disease, though its loss promotes B cell ...
Lu Chen, Yu Liu
exaly +2 more sources
The H3K4 methyltransferase KMT2D is an essential cofactor for GATA1 at erythroid gene enhancers [PDF]
Gene expression during cellular differentiation is coordinated by combinatorial interactions between transcription factors (TFs) and cofactors. Although the TF GATA1 coordinates gene transcription in hematopoiesis, the specific cofactors required for ...
Jianxiang Zhang +14 more
doaj +2 more sources
Chromatin modifiers KMT2D, cBAF, and p300 cooperatively facilitate de novo binding of transcription factors on enhancers [PDF]
Transcription factors (TFs) bind to enhancers and recruit H3K4me1 methyltransferase KMT2D, chromatin remodeler cBAF, and H3K27 acetyltransferase p300 to activate transcription. However, the role of chromatin modifiers in regulating de novo binding of TFs
Hieu T. Van +9 more
doaj +2 more sources
KMT2D-deficiency destabilizes lineage progression in immature neural progenitors [PDF]
Neurodevelopment is driven by the tightly regulated integration of chromatin shaping, transcription, and proliferation. Although KMT2D is known to catalyze activating H3K4 methylation marks at promoters and enhancers, its role in regulating early fate ...
Carly S. Golden +6 more
doaj +2 more sources

